These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Factors associated with the development of cytomegalovirus infection following solid organ transplantation. da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196 [TBL] [Abstract][Full Text] [Related]
48. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. DesJardin JA; Cho E; Supran S; Gibbons L; Werner BG; Snydman DR Clin Infect Dis; 2001 Oct; 33(8):1358-62. PubMed ID: 11565077 [TBL] [Abstract][Full Text] [Related]
49. Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus-seronegative liver transplant recipients of cytomegalovirus-seropositive donor allografts. Singh N; Wannstedt C; Keyes L; Mayher D; Tickerhoof L; Akoad M; Wagener MM; Cacciarelli TV Liver Transpl; 2008 Feb; 14(2):240-4. PubMed ID: 18236404 [TBL] [Abstract][Full Text] [Related]
51. Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis. Kuo HT; Ye X; Sampaio MS; Reddy P; Bunnapradist S Transplantation; 2010 Nov; 90(10):1091-8. PubMed ID: 20885340 [TBL] [Abstract][Full Text] [Related]
52. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression. Shah AP; Chen JM; Fridell JA Clin Transplant; 2015 Dec; 29(12):1221-9. PubMed ID: 26458498 [TBL] [Abstract][Full Text] [Related]
53. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation. Weir MR; Henry ML; Blackmore M; Smith J; First MR; Irwin B; Shen S; Genemans G; Alexander JW; Corry RJ Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352 [TBL] [Abstract][Full Text] [Related]
54. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581 [TBL] [Abstract][Full Text] [Related]
55. Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States. Kurihara C; Fernandez R; Safaeinili N; Akbarpour M; Wu Q; Budinger GRS; Bharat A Ann Thorac Surg; 2019 Apr; 107(4):1046-1052. PubMed ID: 30476471 [TBL] [Abstract][Full Text] [Related]